Eye-brain imaging for diabetes-related thinking problems
Treatments studied
Part of Eyes & vision, Heart & circulation, Hormones & metabolism, Mental health clinical trials.
This study is testing a new way to look at the connection between your eyes and brain using special imaging. It aims to see if this imaging can help manage diabetes-related thinking problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes diagnosed by a doctor (using standard criteria from 1999).
- You have mild cognitive impairment linked to your diabetes.
- You are between 18 and 70 years old.
- Your most recent A1c (average blood sugar over 3 months) is 9% or lower.
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a better way to diagnose and manage eye problems (diabetic retinopathy) in people with type 2 diabetes. It aims to improve how doctors find and treat these issues to help protect your vision.
This study uses artificial intelligence to analyze retinal images and predict the risk of nerve-related problems caused by diabetes. It may help identify those at risk before symptoms appear.
This study tests a new camera software to help general practitioners check for diabetic retinopathy, an eye problem caused by diabetes. It is for people with type 1 or 2 diabetes who are 40 or older.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study tests whether advanced eye imaging can predict how diabetic eye disease (retinopathy) may worsen over time. If you have type 2 diabetes and early to moderate diabetic retinopathy without swelling in the central part of the retina, you may be able to join.
This study uses a special eye imaging test called OCT angiography to look at tiny blood vessels in the back of the eye. It aims to understand changes caused by diabetic retinopathy, which could help improve how we monitor and treat this condition.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.